Impact of immigration in presentation and outcomes of hepatocellular carcinoma in the USA

European Journal of Gastroenterology & Hepatology
Ashraf A AshhabJose D Debes

Abstract

Hepatocellular carcinoma's (HCC) epidemiology and prognosis differs among regions across the globe, largely because of environmental factors and underlying liver disease. Little is known about the changes led by immigration and the effect on HCC outcome. We aimed to understand the effect of immigration on HCC. A retrospective cohort study of patients diagnosed with HCC was carried out in a tertiary center in the USA between 2005 and 2016. We characterized individuals as US born or having immigrated there after being born elsewhere. Variables related to clinical presentation, surveillance, therapy, and survival were evaluated. A total of 232 HCC cases were included, 169 US born (73%) and 63 immigrants (27%). Both groups were diagnosed with HCC at similar ages (60 vs. 62 years, P=0.13). Hepatitis C was the most common underlying liver disease in the US-born population compared with the immigrant population (83 vs. 52%, P<0.001), whereas hepatitis B was more common in the latter (4 vs. 29%, P<0.001). Interestingly, hepatitis B virus-related HCC was diagnosed at similar ages in US-born and immigrant individuals (59 and 57 years). At the time of diagnosis, both populations had similar tumor sizes, rates of metastasis, and diagnosis ...Continue Reading

References

Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Dec 22, 2009·Journal of Hepatology·Tommaso A Dragani
Jan 30, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giuseppe CabibboCalogero Cammà
Jun 25, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Helena NordenstedtHashem B El-Serag
Mar 20, 2012·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver, UNKNOWN European Organisation For Research And Treatment Of Cancer
Apr 28, 2012·Gastroenterology·Hashem B El-Serag
Jun 13, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Morris ShermanUNKNOWN AASLD Practice Guidelines Committee
Nov 20, 2012·Hepatitis Monthly·Hui Chen Wu, Regina Santella
May 20, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Hashem B El-Serag, Fasiha Kanwal
Sep 28, 2014·Best Practice & Research. Clinical Gastroenterology·Cristina BosettiCarlo La Vecchia
Dec 3, 2014·Surgical Oncology Clinics of North America·Maria C Russell
Apr 30, 2015·Clinics in Liver Disease·Katherine A McGlynnW Thomas London
Dec 1, 2015·The American Journal of Gastroenterology·Ju Dong YangUNKNOWN Africa Network for Gastrointestinal and Liver Diseases
Apr 17, 2016·Journal of Hepatology·Massimo Levrero, Jessica Zucman-Rossi
May 10, 2016·Nature Reviews. Disease Primers·Josep M LlovetGregory Gores
Oct 6, 2016·Nature Communications·Ling-Hao ZhaoHong-Yang Wang
Apr 14, 2017·The Lancet. Gastroenterology & Hepatology·Ju Dong YangUNKNOWN Africa Network for Gastrointestinal and Liver Diseases
Oct 5, 2017·Cancer Control : Journal of the Moffitt Cancer Center·Nader N Massarweh, Hashem B El-Serag

❮ Previous
Next ❯

Citations

Sep 7, 2019·European Journal of Gastroenterology & Hepatology·Changqing ZhaoMindie H Nguyen
Jul 16, 2021·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Belaynew W TayePatricia C Valery

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SAS Enterprise Guide

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.